Keyword: Baylor College of Medicine
The past week ushered in news about a toxin in scorpion venom that may relieve RA and a skin bacterium with anti-cancer powers.
CRISPR is a promising treatment for blood disorders, but it comes with challenges, such as off-target effects.
Scientists at Baylor have discovered that when they silence a signaling pathway in the body called Hippo, they can reverse heart failure in mice.
A new target for the treatment of MeCP2 duplication syndrome could be useful in treating autism and other neurological conditions.
Normalizing the blood vessels that feed tumors and gaining a better understanding of how they interact with immune cells could improve cancer treatment, Baylor researchers report.
Cell Medica has raised £60 million ($74 million) to expand its clinical pipeline of cancer cellular immunotherapies.
In a recent effort to characterize new targets of obesity, a collaborative effort has suggested a new mechanism that regulates obesity in the mouse’s brain.
London-based Cell Medica, one of last year’s Fierce 15, has signed a pact with Houston’s Baylor College of Medicine to find and develop next-gen tech for engineering immune cells in tumors.
Baylor College of Medicine scientists show tumor cells use mTOR signaling to recruit these suppressors to promote tumor growth.
The surface protein CTLA-4 has now been shown to be produced and secreted by dendritic cells--findings that may lead to a more effective cancer therapy.